Exelixis, Inc. (EXEL)
NASDAQ·Healthcare·Biotechnology
$58.19
-0.52%
Mkt Cap $14.11B
Analyst Ratings
Buy
3
Hold
12
Sell
0
Price Target (57 analysts)
$50.00
Range $44.00 – $56.00
Implied Upside
-14.1%
Consensus $50.00 vs current $58.19
NASDAQ·Healthcare·Biotechnology
$58.19
-0.52%
Mkt Cap $14.11B
Buy
3
Hold
12
Sell
0
Price Target (57 analysts)
$50.00
Range $44.00 – $56.00
-14.1%
Consensus $50.00 vs current $58.19